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Abstract. An attempt has been made in this paper to review our present understanding of 
luteal function during the periimplantation period and in particular hormonal requirement for 
implantation and maintenance of early pregnancy in the non-human primate.
In a fertile cycle the corpus luteum is apparently rescued from luteolysis by chorionic 
gonadotropin secreted by the implanted blastocyst, In the bonnet monkey the serum 
progesterone titers during the luteal phase of a fertile cycle seems higher compared to that of 
nonmated cycling monkeys. This suggested that the corpus luteum is receiving some 
stimulatory signal from the blastocyst even prior to implantation. The recent demonstration 
that human blastocyst in culture secretes into the medium human chorionic gonadotropin 
essentially support the above assumption. However, attempts to extend the luteal phase of 
cycling unmated monkeys with exogenous human chorionic gonadotropin injection has 
hitherto not met with complete success suggesting that there could be other than chorionic
gonadotropin, additional luteal stimulatory factors the unimplanted blastocyst is secreting.
Corpus luteum is the principle source of both progesterone and estrogen produced during 
the periimplantation period and dysruption of luteal function, brought about by either 
lutectomy or ovariectomy or luteinizing hormone antiserum treatment, followed by pro- 
gesterone supplementation leads to maintenance of pregnancy. This has lead to questioning 
the need for estrogen in the maintenance of early pregnancy. Recent work using 
Zuclomiphene, an antiestrogen during days 5–11 of cycle in rhesus monkeys mated between
day 9–14, has however, suggested that estrogen may be required for implantation. Further
work is needed to arrive at an unequivocal decision regarding the need for estrogen in 
maintenance of early pregnancy in the primate.
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It is presently well accepted that the corpus luteum (CL) is essential in the primate for 
establishment of pregnancy. The CL need apparently ceases once implantation occurs 
and the placenta takes over the function of producing steroids (Booher et al., 1981). The 
period between fertilization and implantation in the non-human primate is around 9 
days (Hendrickx and Enders, 1980) and limited information is known about the events 
occurring during the intervening period. The CL of the fertile mated monkey secretes 
both progesterone and estrogen. Particularly, that the latter is of CL in origin is shown 
by lutectomizing monkeys. Such monkeys in addition to showing drastic and 
immediate reduction in both progesterone and estrogen levels do not respond to 
exogenous luteinizing hormone (LH)/chorionic gonadotropin (CG) treatment (Walsh 
et al., 1979; Wilks and Noble, 1983; Sheela Rani, C. S., Ravindranath, N., Kotagi, S. G.
 
 
Abbreviations used: CL, Corpus luteum; LH, luteinizing hormone; hCG, human chorionic gonadotropin. 
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and Moudgal, Ν. R., unpublished observations). A comparison of serum progesterone 
and estrogen levels of cycling fertile and non-fertile bonnet monkeys between days 
19–23 of cycle shows that the level of both these steroid hormones is significantly high
in the former group (Rao and Moudgal, 1984). Similar observations have been made for 
other primates, notably the rhesus (Atkinson et al. 1975; Hendrickx and Enders, 1980). 
The increase in progesterone levels of cycling fertile bonnet monkeys even prior to 
implantation according to Mukku and Moudgal (1979) is perhaps due to the CL 
receiving some type of signal from the as yet unimplanted blastocyst. The first report 
that the unimplanted blastocyst could be secreting chorionic gonadotropin was made 
by Saxena et al. (1974) and recently Fishel et al. (1984) have obtained confirmatory 
evidence for this by measuring human chorionic gonadotropin (hCG) in culture 
medium of human blastocysts. Attempts to extend the luteal phase of cycling unmated 
monkeys by giving exogenous hCG have, however, generally not met with complete 
success. hCG given daily either in increasing doses (to simulate pregnancy) or 
sustaining small doses from day 18–20 of cycle has lead to increase in progesterone
titers only for a 3–4 day period, the levels falling rapidly thereafter. Continued hCG
injection, however, seems to maintain estrogen at high levels, the cycle length itself 
being extended by a maximum of 5–7 days. These results using both the rhesus (Wilks
and Noble, 1983) and the bonnet (Sheela Rani, C. S., Ravindranath, N., Kotagi, S. G. 
and Moudgal, Ν. R., unpublished observations) suggest that in addition to hCG, 
perhaps the CL during the preimplantation period is receiving some other stimulus 
from the blastocyst to keep producing high titers of progesterone. The nature of this 
stimulus is yet to be ascertained.
Based essentially on morphological/histological criteria it has been concluded that 
implantation in most of the non-human primates examined thus far occurs ap- 
proximately 9 days after fertilization (Hearn, 1980). This day could coincide with the 
day of CL rescue as determined in non-fertile cycling monkeys (Atkinson et al., 1975). 
In the bonnet monkeys, based on the in vitro sensitivity of CL, removed on days 19,23, 
25 and 28 of cycle to exogenous LH it was concluded that the CL rescue must be 
occurring on or about day 23, 9–10 days after fertilization (Mukku and Moudgal,
1979). At present other than measurement of elevation in hormone levels (progesterone 
and CG for example) there is no other way, except by morphological examination, to fix 
the time of implantation. With the advent of newer protein separation techniques which 
will permit isolation of specific protein in small quantities (see paper by Roberts in this 
issue) coupled to radioimmunoassay we can hope that a specific marker protein will be 
isolated from blastocysts in culture which will permit us to arrive at the time of 
implantation little more accurately.
Paralleling the increase in CG levels, first detectable in the serum of bonnet monkeys 
by day 28 of cycle there is a significant increase in both estradiol and testosterone levels 
(Rao and Moudgal, 1984). While the need for progesterone in implantation and 
maintenance of pregnancy is fairly well established that of estrogen in these events is 
questioned. Meyer et al. (1969) thus observed using rhesus monkeys ovariectomized on 
day 6/7 post fertilization that it is possible to obtain implantation and pregnancy 
maintenance by supplementing with progesterone alone. Bosu and Johansson (1975), 
however, report that induction of implantation and/or maintenance of pregnancy was 
poor in ovariectomized monkeys maintained on progesterone alone. Dosing of mated
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cycling bonnet monkeys with antisera to oLH or its β subunit (a/s) from days 18–20
post fertilization has been shown to reduce drastically serum progesterone and 
estrogen levels, this leading ultimately to the termination of pregnancy (Prahalada et 
al., 1975; Moudgal et al., 1978). However, supplementing a/s treated monkeys with 
varying doses of progesterone permits continuation of normal pregnancy suggesting 
that in the bonnet monkey progesterone alone is adequate to maintain pregnancy 
during the periimplantation period (Sheela Rani, C. S., Ravindranath, N., Kotagi, S. G. 
and Moudgal, Ν. R., unpublished observations).
In the rodents, particularly in rats and mice the requirement for estrogen in the 
implantation process is well established. Implantation in the hamster, though believed 
till recently to be solely progesterone dependent has been shown to improve (by 
increase in the number of implantation sites) with estrogen supplementation (Sengupta 
et al., 1981). Recent studies have shown that the unimplanted blastocyst (Sengupta et 
al.,1984) as well as the uterine endometrium have the ability to synthesize estrogen. In 
the light of this, perhaps some of the experiments done in ovariectomized or a/s treated 
monkeys supplemented with progesterone need to be re-examined. The use of 
medroxyprogesterone acetate, a non metabolizable progestational compound instead 
of progesterone in the above studies might provide more definitive result. Alternately a 
higher titer estrogen antibody or a specific aromatase inhibitor or a chemical analogue 
having potent antiestrogenic activity will have to be used to establish beyond any doubt 
the need for estrogen.
Recent work of Adiga et al. (1983) provides supporting evidence for the need for 
estrogen to support pregnancy. They have established that estrogen induces the 
synthesis of a series of vitamin carrier proteins in both the pregnant rodent and primate 
(Adiga, P. R., personal communication). Using a pregnant rat as the experimental model 
they have shown that there is a critical need for these estrogen induced proteins in 
transporting vitamins across the placenta to the growing foetus, neutralization of these 
proteins with specific antibodies resulting in the termination of pregnancy. It is, 
however, not yet clear from their studies, if this ‘critical’ requirement extends to the
primate and if so whether this need is felt during the preimplantation period itself.
The use of a variety of antiestrogens to study the role of estrogens in implantation per 
se in the primate has generally not been successful (Prasad and Sankaran, 1975). This 
failure has been attributed by some workers to the doses used and in particular to the 
time of administration of the drug. Assuming that the estrogen surge that occurs at mid 
cycle may be adequate to sensitize the uterus for subsequent progesterone action, 
Zuclomiphene, a potent antiestrogen has been administered to rhesus monkeys 
between days 5–11 of cycle in doses (2 mg/kg/day) that presumably did not effect
estrogen function at the hypothalmo-pituitary end. Such a treatment has been shown to 
render these monkeys infertile (Sankaran Μ. S., Prahalada S. and Hendrickx A. G., 
personal communication). Though it is suggested that clomiphene could be acting here 
as an anti-implantation agent by interfering with the sensitization of uterus to 
progesterone, the possibility that it could also be acting by bringing about premature 
expulsion of fertilized ova from the follopian tube cannot be excluded.
In summary, though the need for a functional CL to support pregnancy during the 
periimplantation period is well established there is as yet no clear-cut evidence to 
suggest that estrogen is needed for either implantation or immediate post-implantation
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survival of the blastocyst. The work of Sankaran and his co-workers (Sankaran, M. S., 
Prahalada, S. and Hendrickx, A. G., personal communication) is a pointer in this 
direction, but further work needs to be done to establish estrogen requirement beyond 
any doubt. A more accurate biochemical marker for implantation as well as mapping of 
steroid receptor levels during the periimplantation period in the primate is also 
required and may together help in better understanding the role of steroid hormones in 
implantation. 
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